Retention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapy

Seminars in Thrombosis and Hemostasis

Volumn 31, Issue 4, 2005, Pages 441-448

  Wieding, Jörk Ulrich ^a,b   Matern, Juliane ^b   Köstering, Heinz ^b   Wermes, Cornelia ^c   Wenzel, Ernst ^d  

^a University Hospital of Göttingen ^*  (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

Desmopressin; Platelet adhesion; Platelets; von Willebrand disease; von Willebrand factor

Indexed keywords

ACETYLSALICYLIC ACID; ANTIGEN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN; RISTOCETIN COFACTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

BLEEDING; BLOOD CLOTTING PARAMETERS; BLOOD FILTER; BLOOD TRANSFUSION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG MONITORING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; KINETICS; NORMAL HUMAN; PLATELET RETENTION TEST HOMBURG; PRIORITY JOURNAL; SUBSTITUTION THERAPY; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ASPIRIN; BLOOD PLATELETS; CELL ADHESION; DEAMINO ARGININE VASOPRESSIN; DRUG MONITORING; FACTOR VIII; HEMOSTATICS; HUMANS; KINETICS; PLATELET ADHESIVENESS; PLATELET FUNCTION TESTS; POLYURETHANES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 4344630394     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916679     Document Type: Conference Paper

References (20)

1. Furlan M. von Willebrand factor: molecular size and functional activity. Ann Hematol 1996;72:341-348
2. de Groot PG. The role of von Willebrand factor in platelet function. Semin Thromb Hemost 2002;28:133-138
3. Scott JP, Montgomery RR. Therapy of von Willebrand disease. Semin Thromb Hemost 1993;19:37-47
4. Ruggeri ZM, Dent JW, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999;94:172-178
5. Ruggeri ZM. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 2001;14:257-279
6. Siekmann J, Turecek PL, Schwartz HP. The determination of von Willebrand factor activity by collagen binding assay. Haemophilia 1998;4:15-24
7. Mannucci PM. Treatment of von Willebrand disease. Thromb Haemost 2001;86:149-153
8. Lethagen S, Berntorp E, Nilsson IM. Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III. Ann Hematol 1992;65:253-259
9. Mannucci PM, Tenconi PM, Castaman G, Rodeghiero F. Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial. Blood 1992;79:3130-3137
10. Lillicrap D, Poon MC, Walker I, Xie F, Schwartz BA. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, Haemate-P/Humate-P: Ristocetin cofactor unit dosing in patients with von Willebrand disease. Thromb Haemost 2002;87:224-230
11. Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202
12. Schumann A, Bucha E, Nowa G. Platelet adhesion assay PADA). Semin Thromb Hemost 2005;31:476-481
13. Hellem AJ. Platelet adhesiveness in von Willebrand's disease. A study with a new modification of the glass bead filter method. Scand J Haematol 1970;7:374-382
14. Salzman EW. Measurement of platelet adhesiveness: a simple in vitro technique demonstrating an abnormality in von Willebrand's disease. J Lab Clin Med 1963;62:724-735
15. Niessner H. Messung der Plattchenadhäsivität mit einer modifizierten Form der Hellem II-Methodik unter besonderer Berücksichtigung des von Willebrand-Jürgens-Syndroms [Measurement of platelet adhesiveness using a modified form of the Hellem II method with special reference to Willebrand-Jurgens syndrome]. Thromb Diath Haemorrh 1972;27:434-451
16. Kenet G, Lubetsky A, Shenkman B, et al. Cone and platelet analyser (CPA): a new test for the prediction of bleeding among thrombocytopenic patients. Br J Haematol 1998;101:255-259
17. Sakariassen KS, Aarts PA, de Groot PG, Houdijk WP, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983;102:522-535
18. Reininger AJ, Agneskirchner J, Bode PA, Spannagl M, Wurzinger LJ. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor. Thromb Haemost 2000;83:217-223
19. Wieding JU, Köstering H, Peine S, Wermes C, Mestres P, Wenzel E. Plättchen-Retentionstest Homburg: Drug monitoring der Plä ttchenadhäsivität des von Willebrandfaktors [Platelet retention test Homburg (RTH) and drug monitoring of platelet adhesive properties of von Willebrand factor]. Haemostaseologie 2004;24:217-220
20. Merrill EW, Salzman EW, Wan S, et al. Platelet-compatible hydrophilic segmented polyurethanes from polyethylene glycols and cyclohexane diisocyanate. Trans Am Soc Artif Intern Organs 1982;28:482-487